Quitadamo Paolo, Isoldi Sara, Mallardo Saverio, Zenzeri Letizia, Di Nardo Giovanni
Department of Pediatrics, A.O.R.N. Santobono-Pausilipon, Naples, Italy.
Maternal and Child Health Department, Sapienza - University of Rome, Santa Maria Goretti Hospital, Polo Pontino, Latina, Italy.
Curr Pediatr Rev. 2021;17(2):92-102. doi: 10.2174/1573396317666210127123330.
Irritable bowel syndrome (IBS) is one of the most common functional gastro-intestinal disorders which significantly impacts the quality of life of affected children. Abdominal pain improved by defecation, associated with a change in stool form and frequency, represents its specific clinical marker. Even if a number of potential patho-physiological mechanisms have been described, the exact underlying etiology of IBS is so far unclear. Likewise, no optimal treatment has ever been found neither for adult nor for pediatric patients. Current therapeutic options include drugs, dietary interventions and biopsychosocial therapies. The present review aims at evaluating the scientific evidence supporting the efficacy of these treatments for children with IBS.
肠易激综合征(IBS)是最常见的功能性胃肠疾病之一,严重影响患病儿童的生活质量。排便后腹痛缓解,伴有大便形状和频率改变,是其特定的临床标志。尽管已经描述了许多潜在的病理生理机制,但迄今为止,IBS的确切病因尚不清楚。同样,无论是成人还是儿童患者,都尚未找到最佳治疗方法。目前的治疗选择包括药物、饮食干预和生物心理社会疗法。本综述旨在评估支持这些治疗方法对IBS患儿疗效的科学证据。